title: Mitoxantrone and GM-CSF: a phase I study with an escalated dose of mitoxantrone in breast cancer.
authors.affiliation: The Netherlands Cancer Institute, Amsterdam.
authors.forename: W W
authors.initials: WW
authors.lastname: ten Bokkel Huinink
authors.forename: M
authors.initials: M
authors.lastname: Clavel
authors.forename: S
authors.initials: S
authors.lastname: Rodenhuis
authors.forename: J P
authors.initials: JP
authors.lastname: Guastalla
authors.forename: H R
authors.initials: HR
authors.lastname: Franklin
authors.forename: J J
authors.initials: JJ
authors.lastname: Koier
authors.forename: T
authors.initials: T
authors.lastname: Vlasveld
authors.forename: O
authors.initials: O
authors.lastname: Dalesio
authors.forename: H
authors.initials: H
authors.lastname: van Tinteren
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control*; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D008942:Mitoxantrone